| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.8 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |